Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Semen Baturaja Tbk. (SMBR)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Semen Baturaja Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Semen Baturaja Tbk. diperdagangkan di Rp172 (kapitalisasi pasar 1,74 T, volume 24 jam 5,09 jt). Perbedaan utamanya: Semen Baturaja Tbk. jauh lebih besar — sekitar 16,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SMBR | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 1,74 T |
Volume | — | 5,09 jt |
Lot | — | 50,91 rb |
Perputaran | — | 871,41 jt |
Harga Rata-rata | — | 171,16 |
Nilai Transaksi | — | 871,41 jt |
Harga Ekuilibrium Indikatif | — | 172 |
Volume Ekuilibrium Indikatif | — | 150 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Semen Baturaja Tbk.
PT Semen Baturaja (Persero) Tbk (the Company) was established by Deed of Notary Jony Frederik Berthold Tumbelaka Sinjai No. 34, in Jakarta, dated November 14, 1974, amended by the same notary on November 21, 1974, amended by the same notary on November 21, 1974 Deed No. 49.
Selengkapnya di halaman SMBR →
